S1PR3 and fatty liver disease: In contrast, Chakrabarty et al. recently revealed that the mRNA levels of S1PR3 are increased in the AT of HFD-induced obese mice, whereas adiposity and glucose homeostasis were impaired in mice deficient in S1PR3, and adipose tissue inflammation and immune cell accumulation were elevated with accompanying hepatic steatosis and inflammation [52].